Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1952 2
1953 1
1955 2
1963 1
1966 1
1982 1
1983 3
1984 1
1985 1
1986 1
1987 1
1989 1
1990 2
1994 2
2000 3
2001 1
2002 2
2003 2
2004 1
2005 3
2006 3
2007 3
2008 3
2009 2
2010 7
2011 23
2012 25
2013 18
2014 21
2015 23
2016 18
2017 4
2018 2
2019 5
2020 11
2021 7
2022 10
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Results by year

Filters applied: . Clear all
Page 1
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Sartore-Bianchi A, Pietrantonio F, Lonardi S, Mussolin B, Rua F, Crisafulli G, Bartolini A, Fenocchio E, Amatu A, Manca P, Bergamo F, Tosi F, Mauri G, Ambrosini M, Daniel F, Torri V, Vanzulli A, Regge D, Cappello G, Marchiò C, Berrino E, Sapino A, Marsoni S, Siena S, Bardelli A. Sartore-Bianchi A, et al. Among authors: cappello g. Nat Med. 2022 Aug;28(8):1612-1618. doi: 10.1038/s41591-022-01886-0. Epub 2022 Aug 1. Nat Med. 2022. PMID: 35915157 Free PMC article. Clinical Trial.
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial.
Sartore-Bianchi A, Lonardi S, Martino C, Fenocchio E, Tosi F, Ghezzi S, Leone F, Bergamo F, Zagonel V, Ciardiello F, Ardizzoni A, Amatu A, Bencardino K, Valtorta E, Grassi E, Torri V, Bonoldi E, Sapino A, Vanzulli A, Regge D, Cappello G, Bardelli A, Trusolino L, Marsoni S, Siena S. Sartore-Bianchi A, et al. Among authors: cappello g. ESMO Open. 2020 Sep;5(5):e000911. doi: 10.1136/esmoopen-2020-000911. ESMO Open. 2020. PMID: 32988996 Free PMC article. Clinical Trial.
Gastrointestinal adverse events of immunotherapy.
Cappello G, Molea F, Campanella D, Galioto F, Russo F, Regge D. Cappello G, et al. BJR Open. 2021 Oct 20;3(1):20210027. doi: 10.1259/bjro.20210027. eCollection 2021. BJR Open. 2021. PMID: 35707753 Free PMC article. Review.
Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy.
Vani V, Regge D, Cappello G, Gabelloni M, Neri E. Vani V, et al. Among authors: cappello g. Diagnostics (Basel). 2020 Apr 13;10(4):216. doi: 10.3390/diagnostics10040216. Diagnostics (Basel). 2020. PMID: 32294888 Free PMC article. Review.
The EGNOS Augmentation in Maritime Navigation.
Innac A, Angrisano A, Del Pizzo S, Cappello G, Gaglione S. Innac A, et al. Among authors: cappello g. Sensors (Basel). 2022 Jan 20;22(3):775. doi: 10.3390/s22030775. Sensors (Basel). 2022. PMID: 35161521 Free PMC article.
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST).
Cappello G, Giannini V, Cannella R, Tabone E, Ambrosini I, Molea F, Damiani N, Landolfi I, Serra G, Porrello G, Gozzo C, Incorvaia L, Badalamenti G, Grignani G, Merlini A, D'Ambrosio L, Bartolotta TV, Regge D. Cappello G, et al. Eur J Radiol Open. 2023 Jul 10;11:100505. doi: 10.1016/j.ejro.2023.100505. eCollection 2023 Dec. Eur J Radiol Open. 2023. PMID: 37484979 Free PMC article.
221 results